Sepsis & infection

Predictive enrichment using biomarkers in studies of critically-ill patients with sepsis: a systematic review

Crit CarePublished Systematic review

Authors' conclusion

Although the studies were heterogeneous in design and limited in number, those that employed biomarker-based enrichment strategies demonstrate a promising signal for enhanced clinical trial efficiency.

Study context

Population
Randomized controlled trials (RCTs) enrolling adults with sepsis that used molecular biomarkers for predictive enrichment12 studies
Outcome
Use of biomarkers for predictive enrichment and trial outcomes
Methodological detailsPRISMA-ScR, narrative synthesis without statistical pooling, Cochrane Risk of Bias tool
  • PRISMA-ScR
  • Narrative synthesis without statistical pooling
  • Cochrane Risk of Bias tool

Pooled result

As reported in the abstract

Studies included (of 1,718 citations)
12
Studies with statistically significant impact on the primary outcome
Five studies (42%)
Patient-important benefit (reduced mortality or disease severity)
three
Improvement in biomarker-related surrogate outcomes
two

Original publication

Predictive enrichment using biomarkers in studies of critically-ill patients with sepsis: a systematic review. Crit Care. Published 27 November 2025. doi:10.1186/s13054-025-05684-1

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.